Michael Andrew Schemick net worth and biography

Michael Schemick Biography and Net Worth

CFO of Certara
Mr. Schemick joined Certara as Chief Financial Officer in August 2014. He brings 19 years of financial management experience to the company in a wide range of industries, including software and consulting organizations. Before Certara, Schemick served as Vice President of Financial Planning and Analysis for Haights Cross Communications, a holding company for education and media investments, playing a key role in business transformation, strategy, and financial operations on behalf of private equity investors. Schemick also held Chief Financial Officer roles for two divisions of Kaplan Inc, a leading education company, and has significant experience in both public and private equity backed enterprises. Schemick started his career at Arthur Andersen after graduating with an MBA in accounting from Rutgers University. In addition, he has earned the titles of CPA and CTP.

What is Michael Andrew Schemick's net worth?

The estimated net worth of Michael Andrew Schemick is at least $6.88 million as of August 17th, 2022. Mr. Schemick owns 517,870 shares of Certara stock worth more than $6,877,314 as of September 28th. This net worth approximation does not reflect any other investments that Mr. Schemick may own. Learn More about Michael Andrew Schemick's net worth.

How do I contact Michael Andrew Schemick?

The corporate mailing address for Mr. Schemick and other Certara executives is 100 OVERLOOK CENTER SUITE 101, PRINCETON NJ, 08540. Certara can also be reached via phone at 609-716-7900 and via email at [email protected] Learn More on Michael Andrew Schemick's contact information.

Has Michael Andrew Schemick been buying or selling shares of Certara?

During the last quarter, Michael Andrew Schemick has bought $416,000.00 in Certara stock. Most recently, on Wednesday, August 17th, Michael Andrew Schemick bought 25,000 shares of Certara stock. The stock was acquired at an average cost of $16.64 per share, with a total value of $416,000.00. Following the completion of the transaction, the chief financial officer now directly owns 517,870 shares of the company's stock, valued at $8,617,356.80. Learn More on Michael Andrew Schemick's trading history.

Who are Certara's active insiders?

Certara's insider roster includes Robert Aspbury (Insider), James Cashman, III (Director), Jieun Choe (Insider), Justin Edge (Insider), William Feehery (CEO), Craig Rayner (Insider), Michael Schemick (CFO), Mason Slaine (Director), Patrick Smith (Insider), and Richard Traynor (SVP). Learn More on Certara's active insiders.

Are insiders buying or selling shares of Certara?

During the last year, Certara insiders bought shares 2 times. They purchased a total of 45,000 shares worth more than $742,400.00. During the last year, insiders at the sold shares 38 times. They sold a total of 17,501,795 shares worth more than $427,507,408.36. The most recent insider tranaction occured on August, 19th when Director Stephen M Mclean bought 20,000 shares worth more than $326,400.00. Insiders at Certara own 4.0 % of the company. Learn More about insider trades at Certara.

Information on this page was last updated on 8/19/2022.

Michael Andrew Schemick Insider Trading History at Certara

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/17/2022Buy25,000$16.64$416,000.00517,870View SEC Filing Icon  
11/15/2021Sell66,666$37.84$2,522,641.44View SEC Filing Icon  
10/18/2021Sell66,667$36.48$2,432,012.16View SEC Filing Icon  
9/20/2021Sell66,667$34.62$2,308,011.54View SEC Filing Icon  
6/22/2021Sell66,666$26.94$1,795,982.04830,177View SEC Filing Icon  
See Full Table

Michael Andrew Schemick Buying and Selling Activity at Certara

This chart shows Michael Andrew Schemick's buying and selling at Certara by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Certara Company Overview

Certara logo
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $13.28
Low: $12.92
High: $13.29

50 Day Range

MA: $17.87
Low: $12.84
High: $24.13

2 Week Range

Now: $13.28
Low: $12.58
High: $45.48


19,143 shs

Average Volume

764,248 shs

Market Capitalization

$2.12 billion

P/E Ratio


Dividend Yield